Results 131 to 140 of about 16,174 (186)
Some of the next articles are maybe not open access.

Thromboprophylaxis

2023
Abstract Summary Venous thromboembolism (VTE) is a global health burden of which critically unwell patients are at high risk. Current accepted practice and background evidence for the use of mechanical and pharmacological prophylaxis are reviewed.
Emma Louise Hartley, Andrew Retter
openaire   +1 more source

Thromboprophylaxis in multiple myeloma

Leukemia & Lymphoma, 2022
Venous thromboembolism (VTE) in multiple myeloma (MM) can be secondary to patient-, disease-, and/or treatment-related factors. The development of VTE may result in significant morbidity with the highest risk during the first year after diagnosis. This clinical review provides an evidence-based summary to guide practicing oncologists in the use of ...
Nishanth, Thalambedu, Samer, Al Hadidi
openaire   +2 more sources

Thromboprophylaxis in Microsurgery

Acta Chirurgica Belgica, 2006
Microsurgical free tissue transfer has become a gold standard in a wide range of clinical situations. Thrombosis at the anastomotic site is not only the most common cause of failure of microsurgical operations, but it is also one of the factors resulting in microcirculatory intravascular thrombosis in free flaps.
Lecoq, Jean-Pierre   +4 more
openaire   +2 more sources

Postinjury thromboprophylaxis

Current Opinion in Critical Care, 2008
In trauma patients, pulmonary embolism occurs in up to 4% of cases and carries a mortality of 20-50%. The incidence of deep vein thrombosis (DVT) varies from 5 to 63% depending on patients' risk factors, modality of prophylaxis, and methods of detection.
Bendinelli, Cino, Balogh, Zsolt
openaire   +2 more sources

Thromboprophylaxis in Pregnancy

Obstetrics and Gynecology Clinics of North America, 2018
Venous thromboembolism is a leading cause of maternal morbidity and mortality worldwide. Identifying women who are at greatest risk for venous thromboembolism, and managing their pregnancies with appropriate thromboprophylaxis is essential to decreasing this life-threatening condition. Those at greatest risk are patients with thrombophilias, a personal
Diana, Kolettis, Sabrina, Craigo
openaire   +2 more sources

Thromboprophylaxis in the Cancer Patient

Pathophysiology of Haemostasis and Thrombosis, 1998
Thrombosis is a common complication in patients with malignant disease resulting from tumour elaboration of procoagulants and subsequent activation of intravascular coagulation. Cancer therapies (operation, chemotherapy and the use of central venous lines) further heighten the risk of thrombosis.
A K, Kakkar, R C, Williamson
openaire   +2 more sources

Thromboprophylaxis in Cancer Patients

Seminars in Thrombosis and Hemostasis, 2014
Cancer-associated thrombosis (CAT) is frequent and associated with significant morbidity and mortality among cancer patients. Hospitalized medically ill cancer patients are considered to be at high risk of CAT complications. Parenteral thromboprophylaxis with low-molecular-weight heparin is likely to reduce the risk of venous thromboembolism in this ...
Marc, Carrier, Agnes Y Y, Lee
openaire   +2 more sources

Thromboprophylaxis in Spinal Surgery

Spine, 2018
Study Design. Systematic review and meta-analysis. Objective. Determine the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) in spinal surgery patients receiving no thromboprophylaxis, mechanoprophylaxis, and chemoprophylaxis ...
William P, Mosenthal   +6 more
openaire   +2 more sources

Thromboprophylaxis in neurosurgical patients

Seminars in Hematology, 2000
Neurosurgical patients constitute one of the highest risk groups for postoperative thromboembolic complications. Physical methods of thromboprophylaxis have been successful in reducing the incidence of postoperative deep vein thrombosis (DVT) but the residual incidence remains considerable.
openaire   +2 more sources

Thromboprophylaxis.

British journal of hospital medicine, 1993
Thromboembolic disease causes significant morbidity and mortality. This article evaluates those patients at risk and the thromboprophylactic strategies that may be employed.
R, Grace, B J, Hunt
openaire   +1 more source

Home - About - Disclaimer - Privacy